{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:25:34Z","timestamp":1791804334442,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,18]]},"DOI":"10.7759\/cureus.69635","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:55:07Z","timestamp":1726649707000},"source":"Crossref","is-referenced-by-count":6,"title":["Diagnosis and Management of Immune Thrombocytopenia in Paediatrics: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Yash","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revat J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1635687","article-title":"The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States","volume":"31","author":"Shaw J","year":"2020","unstructured":"Shaw J, Kilpatrick K, Eisen M, Tarantino M. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States. Platelets. 2020, 31:307-14. 10.1080\/09537104.2019.1635687","journal-title":"Platelets"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/aob-20-96","article-title":"Pediatric immune thrombocytopenia (ITP) treatment","volume":"6","author":"Kim TO","year":"2021","unstructured":"Kim TO, Despotovic JM. Pediatric immune thrombocytopenia (ITP) treatment. Ann Blood. 2021, 6:4. 10.21037\/aob-20-96","journal-title":"Ann Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0172","article-title":"Immune pathophysiology of autoimmune thrombocytopenic purpura","volume":"16","author":"Semple JW","year":"2002","unstructured":"Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 2002, 16:9-12. 10.1054\/blre.2001.0172","journal-title":"Blood Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5546\/aap.2021.eng.e202","article-title":"Neonatal thrombocytopenia: a review. I. Definitions, differential diagnosis, causes, immune thrombocytopenia","volume":"119","author":"Donato H","year":"2021","unstructured":"Donato H. Neonatal thrombocytopenia: a review. I. Definitions, differential diagnosis, causes, immune thrombocytopenia. Arch Argent Pediatr. 2021, 119:e202-14. 10.5546\/aap.2021.eng.e202","journal-title":"Arch Argent Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e328365d415","article-title":"Novel anticoagulants: bleeding risk and management strategies","volume":"29","author":"Abraham NS","year":"2013","unstructured":"Abraham NS, Castillo DL. Novel anticoagulants: bleeding risk and management strategies. Curr Opin Gastroenterol. 2013, 29:676-83. 10.1097\/MOG.0b013e328365d415","journal-title":"Curr Opin Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0031-3955(05)70431-4","article-title":"Current controversies in the management of idiopathic thrombocytopenic purpura during childhood","volume":"43","author":"Medeiros D","year":"1996","unstructured":"Medeiros D, Buchanan GR. Current controversies in the management of idiopathic thrombocytopenic purpura during childhood. Pediatr Clin North Am. 1996, 43:757-72. 10.1016\/s0031-3955(05)70431-4","journal-title":"Pediatr Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.237","article-title":"Bleeding complications in immune thrombocytopenia","volume":"2015","author":"Arnold DM","year":"2015","unstructured":"Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2015, 2015:237-42. 10.1182\/asheducation-2015.1.237","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0205-1","article-title":"Platelets and innate immunity","volume":"67","author":"Semple JW","year":"2010","unstructured":"Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci. 2010, 67:499-511. 10.1007\/s00018-009-0205-1","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan D","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, et al.. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010, 115:168-86. 10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan R","year":"2004","unstructured":"McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004, 103:1364-9. 10.1182\/blood-2003-08-2672","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.042307.181154","article-title":"Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia","volume":"60","author":"Kuter DJ","year":"2009","unstructured":"Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med. 2009, 60:193-206. 10.1146\/annurev.med.60.042307.181154","journal-title":"Annu Rev Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines DB","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002, 346:995-1008. 10.1056\/NEJMra010501","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.06188","article-title":"Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies","volume":"84","author":"Kuwana M","year":"2006","unstructured":"Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol. 2006, 84:309-15. 10.1532\/IJH97.06188","journal-title":"Int J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.050799","article-title":"Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group","volume":"96","author":"K\u00fchne T","year":"2011","unstructured":"K\u00fchne T, Berchtold W, Michaels LA, et al.. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica. 2011, 96:1831-7. 10.3324\/haematol.2011.050799","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert C","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011, 117:4190-207. 10.1182\/blood-2010-08-302984","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200312001-00011","article-title":"Severe bleeding in idiopathic thrombocytopenic purpura","volume":"25","author":"Bolton-Maggs P","year":"2003","unstructured":"Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003, 25:S47-51. 10.1097\/00043426-200312001-00011","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000027","article-title":"Comparison of platelet parameters in thrombocytopenic patients associated with acute myeloid leukemia and primary immune thrombocytopenia","volume":"25","author":"Kim MJ","year":"2014","unstructured":"Kim MJ, Park PW, Seo YH, et al.. Comparison of platelet parameters in thrombocytopenic patients associated with acute myeloid leukemia and primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 2014, 25:221-5. 10.1097\/MBC.0000000000000027","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000089469","article-title":"Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus","volume":"115","author":"Aleem A","year":"2006","unstructured":"Aleem A, Al-Sugair S. Thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus. Acta Haematol. 2006, 115:68-73. 10.1159\/000089469","journal-title":"Acta Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero F","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, et al.. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009, 113:2386-93. 10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-628461","article-title":"Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP","volume":"126","author":"Frelinger AL 3rd","year":"2015","unstructured":"Frelinger AL 3rd, Grace RF, Gerrits AJ, et al.. Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood. 2015, 126:873-9. 10.1182\/blood-2015-02-628461","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.79","article-title":"Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes","volume":"2017","author":"West AH","year":"2017","unstructured":"West AH, Churpek JE. Old and new tools in the clinical diagnosis of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. 2017, 2017:79-87. 10.1182\/asheducation-2017.1.79","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06024.x","article-title":"The pathogenesis of immune thrombocytopaenic purpura","volume":"133","author":"Cooper N","year":"2006","unstructured":"Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006, 133:364-74. 10.1111\/j.1365-2141.2006.06024.x","journal-title":"Br J Haematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.568","article-title":"Evidence-based management of immune thrombocytopenia: ASH guideline update","volume":"2018","author":"Neunert CE","year":"2018","unstructured":"Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program. 2018, 2018:568-75. 10.1182\/asheducation-2018.1.568","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref24","article-title":"Immune thrombocytopenia: American Society of Hematology Guidelines, 2019","volume":"57","author":"Sahi PK","year":"2020","unstructured":"Sahi PK, Chandra J. Immune thrombocytopenia: American Society of Hematology Guidelines, 2019. Indian Pediatr. 2020, 57:854-6.","journal-title":"Indian Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan D","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, et al.. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019, 3:3780-817. 10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb01887.x","article-title":"Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease","volume":"94","author":"Zeller B","year":"2005","unstructured":"Zeller B, Rajantie J, Hedlund-Treutiger I, Tedg\u00e5rd U, Wesenberg F, Jonsson OG, Henter JI. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 2005, 94:178-84. 10.1111\/j.1651-2227.2005.tb01887.x","journal-title":"Acta Paediatr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2007.06.007","article-title":"Immune thrombocytopenic purpura","volume":"21","author":"Psaila B","year":"2007","unstructured":"Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin North Am. 2007, 21:743-59. 10.1016\/j.hoc.2007.06.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20453","article-title":"Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)","volume":"46","author":"Imbach P","year":"2006","unstructured":"Imbach P, K\u00fchne T, M\u00fcller D, Berchtold W, Zimmerman S, Elalfy M, Buchanan GR. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006, 46:351-6. 10.1002\/pbc.20453","journal-title":"Pediatr Blood Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.09.004","article-title":"Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment","volume":"146","author":"Wang J","year":"2005","unstructured":"Wang J, Wiley JM, Luddy R, Greenberg J, Feuerstein MA, Bussel JB. Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr. 2005, 146:217-21. 10.1016\/j.jpeds.2004.09.004","journal-title":"J Pediatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054626","article-title":"AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP","volume":"355","author":"Bussel JB","year":"2006","unstructured":"Bussel JB, Kuter DJ, George JN, et al.. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006, 355:1672-81. 10.1056\/NEJMoa054626","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03529-z","article-title":"Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia","volume":"117","author":"Isshiki K","year":"2023","unstructured":"Isshiki K, Mori M, Irikura T, et al.. Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia. Int J Hematol. 2023, 117:774-80. 10.1007\/s12185-022-03529-z","journal-title":"Int J Hematol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00129689-200212000-00005","article-title":"Laparoscopic splenectomy for idiopathic thrombocytopenic purpura","volume":"12","author":"Delaitre B","year":"2002","unstructured":"Delaitre B, Blezel E, Samama G, et al.. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Surg Laparosc Endosc Percutan Tech. 2002, 12:412-9. 10.1097\/00129689-200212000-00005","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2009.10.026","article-title":"Predicting response to splenectomy in children with immune thrombocytopenic purpura","volume":"45","author":"Wood JH","year":"2010","unstructured":"Wood JH, Partrick DA, Hays T, Ziegler MM. Predicting response to splenectomy in children with immune thrombocytopenic purpura. J Pediatr Surg. 2010, 45:140-4. 10.1016\/j.jpedsurg.2009.10.026","journal-title":"J Pediatr Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25125","article-title":"Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials","volume":"93","author":"Bussel J","year":"2018","unstructured":"Bussel J, Arnold DM, Grossbard E, et al.. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials. Am J Hematol. 2018, 93:921-30. 10.1002\/ajh.25125","journal-title":"Am J Hematol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02013.x","article-title":"Management of patients with refractory immune thrombocytopenic purpura","volume":"4","author":"George JN","year":"2006","unstructured":"George JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006, 4:1664-72. 10.1111\/j.1538-7836.2006.02013.x","journal-title":"J Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-603365","article-title":"How I treat refractory immune thrombocytopenia","volume":"128","author":"Cuker A","year":"2016","unstructured":"Cuker A, Neunert CE. How I treat refractory immune thrombocytopenia. Blood. 2016, 128:1547-54. 10.1182\/blood-2016-03-603365","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert MP","year":"2017","unstructured":"Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017, 129:2829-35. 10.1182\/blood-2017-03-754119","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.68.68","article-title":"Long-term efficacy and safety of romiplostim treatment of adult patients with chronic immune thrombocytopenia (ITP): final report from an open-label extension study","volume":"116","author":"Kuter DJ","year":"2010","unstructured":"Kuter DJ, Bussel JB, Newland A, et al.. Long-term efficacy and safety of romiplostim treatment of adult patients with chronic immune thrombocytopenia (ITP): final report from an open-label extension study. Blood. 2010, 116:68. 10.1182\/blood.V116.21.68.68","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.07.085","article-title":"ITP following vaccination","volume":"99","author":"David P","year":"2020","unstructured":"David P, Shoenfeld Y. ITP following vaccination. Int J Infect Dis. 2020, 99:243-4. 10.1016\/j.ijid.2020.07.085","journal-title":"Int J Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-138487","article-title":"Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura","volume":"112","author":"Neunert CE","year":"2008","unstructured":"Neunert CE, Buchanan GR, Imbach P, et al.. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008, 112:4003-8. 10.1182\/blood-2008-03-138487","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1080\/10245330500168740","article-title":"Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura","volume":"10","author":"Ferrara M","year":"2005","unstructured":"Ferrara M, Borrelli B, Greco N, et al.. Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura. Hematology. 2005, 10:401-3. 10.1080\/10245330500168740","journal-title":"Hematology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S140932","article-title":"Immune thrombocytopenia: improving quality of life and patient outcomes","volume":"9","author":"Trotter P","year":"2018","unstructured":"Trotter P, Hill QA. Immune thrombocytopenia: improving quality of life and patient outcomes. Patient Relat Outcome Meas. 2018, 9:369-84. 10.2147\/PROM.S140932","journal-title":"Patient Relat Outcome Meas"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/296223-diagnosis-and-management-of-immune-thrombocytopenia-in-paediatrics-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:55:09Z","timestamp":1726649709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/296223-diagnosis-and-management-of-immune-thrombocytopenia-in-paediatrics-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.69635","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}